Your browser doesn't support javascript.
loading
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Santoni, Matteo; Myint, Zin W; Büttner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T; Gilbert, Danielle; Küronya, Zsófia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina-Cerrillo, Javier; Galli, Luca; Bamias, Aristotelis; De Giorgi, Ugo; Zucali, Paolo Andrea; Rizzo, Mimma; Seront, Emmanuel; Popovic, Lazar; Caffo, Orazio; Buti, Sebastiano; Kanesvaran, Ravindran; Kopecky, Jindrich; Kucharz, Jakub; Zeppellini, Annalisa; Fiala, Ondrej; Landmesser, Johannes; Ansari, Jawaher; Giannatempo, Patrizia; Rizzo, Alessandro; Zabalza, Ignacio Ortego; Monteiro, Fernando Sabino M; Battelli, Nicola; Calabrò, Fabio; Porta, Camillo.
Afiliação
  • Santoni M; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100, Macerata, Italy. mattymo@alice.it.
  • Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536-0293, USA.
  • Büttner T; Department of Urology, University Hospital Bonn (UKB), 53127, Bonn, Germany.
  • Takeshita H; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Okada Y; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Lam ET; University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, CO, USA.
  • Gilbert D; University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, CO, USA.
  • Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.
  • Tural D; Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Zuhuratbaba District, Tevfik Saglam St. No: 11, Bakirkoy, Istanbul, Turkey.
  • Pichler R; Department of Urology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Kemp R; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni - 15, Bologna, Italy.
  • Scagliarini S; UOC di Oncologia, Azienda Ospedaliera di Rilievo Nazionale Cardarelli di Napoli, Naples, Italy.
  • Iacovelli R; Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Vau N; Urologic Oncology, Champalimaud Clinical Center, 1400-038, Lisbon, Portugal.
  • Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padua, Italy.
  • Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padua, Italy.
  • Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.
  • Galli L; Oncology Unit 2, University Hospital of Pisa, 56126, Pisa, Italy.
  • Bamias A; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Rizzo M; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Seront E; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Piazza G. Cesare 11, 70124, Bari, Italy.
  • Popovic L; Department of Medical Oncology, Centre Hospitalier de Jolimont, Haine Saint Paul, Belgium.
  • Caffo O; Oncology Institute of Vojvodina, Faculty of Medicine, University Novi Sad, Novi Sad, Serbia.
  • Buti S; Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy.
  • Kanesvaran R; Medical Oncology Unit, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy.
  • Kopecky J; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Kucharz J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Zeppellini A; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Fiala O; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Landmesser J; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Ansari J; Klinik für Urologie, Ratzeburger Allee 160, 23538, Lübeck, Germany.
  • Giannatempo P; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.
  • Rizzo A; Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Zabalza IO; Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico "Don Tonino Bello", I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Monteiro FSM; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Battelli N; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.
  • Calabrò F; Oncology and Hematology Department, Hospital Santa Lucia, SHLS 716 Cj. C, Brasília, DF, 70390-700, Brazil.
  • Porta C; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100, Macerata, Italy.
Cancer Immunol Immunother ; 72(9): 2961-2970, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37248424
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Limite: Female / Humans / Male Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Limite: Female / Humans / Male Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália